Medicines Co
MDCO
MDCO was delisted on the 3rd of January, 2020.
190 hedge funds and large institutions have $3.14B invested in Medicines Co in 2015 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 80 increasing their positions, 56 reducing their positions, and 23 closing their positions.
94% more call options, than puts
Call options by funds: $59.4M | Put options by funds: $30.6M
43% more repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 56
39% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 23
4% more funds holding
Funds holding: 183 → 190 (+7)
1% less capital invested
Capital invested by funds: $3.15B → $3.14B (-$17.2M)
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$46.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$43.3M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$29.4M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$24.8M |
| 5 |
AWG
Alpha Wave Global
New York
|
+$24.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$57.7M |
| 2 |
PC
PointState Capital
New York
|
-$39.2M |
| 3 |
CI
Cambiar Investors
Denver,
Colorado
|
-$35.9M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$26.5M |
| 5 |
AA
Antipodean Advisors
New York
|
-$26.2M |
MDCO Hedge Fund Activity: Q4 2015 in Review
190 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q4 2015, worth a combined $3.14B — down 0.55% from $3.15B a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new MDCO positions and 23 closed out — a net gain of 9 holders — while 80 added to existing stakes and 56 trimmed.
The largest buyer was AllianceBernstein, adding an estimated $46.5M. The largest seller was Millennium Management, cutting an estimated $57.7M.
- 190 institutional investors held Medicines Co (MDCO) as of Q4 2015, up from 183 in Q3 2015.
- Funds reported $3.14B of Medicines Co stock for Q4 2015, down 0.55% quarter-over-quarter.
- 32 funds opened new Medicines Co positions in Q4 2015 and 23 closed out, a net change of +9 holders.
- The largest Medicines Co buyer in Q4 2015 was AllianceBernstein, an estimated $46.5M added.
- The largest Medicines Co seller in Q4 2015 was Millennium Management, an estimated $57.7M sold.
Based on aggregated 13F filings for Q4 2015.